+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

From
From
From
From
Pulmonary Drug Delivery Market & Clinical Pipeline Insight - Product Thumbnail Image

Pulmonary Drug Delivery Market & Clinical Pipeline Insight

  • Drug Pipelines
  • May 2014
  • 890 Pages
From
From
From
From
From
Asthma - Pipeline Review, H2 2020 - Product Thumbnail Image

Asthma - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 811 pages
From
From
From
From
Cystic Fibrosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 550 pages
From
Loading Indicator
adroll